Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) will start trading on Nasdaq First North Stockholm under the ticker PERP B today.

Following the extraordinary general meeting’s resolution to adopt a new articles of association, the Swedish Companies Registration Office (Swe: Bolagsverket) has approved the company’s submission, after which Nasdaq has approved the application to change the name of the company. The first day of trading will take place today, April 23, 2024, under the ticker PERP B.

The new name reflects the company’s ambition to be a long-term owner of profitable companies operating in the healthcare sector. The businesses and the decision-making are intended to take place in the independent subsidiaries.

Erik Hedlund, Chairman of the Board and main shareholder of Perpetua Medical AB, comments: We are working intensively together with the incoming CEO to build a sustainable business with a new strategy. We are in ongoing discussions with several companies within the healthcare sector that are profitable today and have growth potential.

For more information contact:

Erik Hedlund, Chairman

Phone: +46 70-382 08 41

About Perpetua Medical AB

Perpetua Medical AB (publ), formerly Pharmacolog i Uppsala AB, is a company active in the healthcare sector and with headquarter in Uppsala, Sweden. The company’s shares (ticker PERP B) are traded on Nasdaq First North Stockholm.

The following trademarks are owned and protected by Perpetua Medical AB: Pharmacolog™-logo, WasteLog™and Pharmacolog Dashboard™.

Further information regarding the company is available at

The company’s Certified Adviser is Mangold Fondkommission AB.


Send download link

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.